News
ABEO
3.190
+0.63%
0.020
Abeona Therapeutics: Key Director Elections and Share Resolutions Passed
TipRanks · 1d ago
U.S. RESEARCH ROUNDUP-Airbnb, American Express, Mattel
Wall Street analysts revise their ratings and price targets on several U.S. Listed companies. American Express Co, Mattel and Amazon.com among those revised. Analysts raise target prices for American Express, Amazon, Fiserv and other companies. Airbnb, American Express and Mattel raise to buy from Mizuho.
Reuters · 1d ago
ABEONA THERAPEUTICS INC <ABEO.O>: JEFFERIES CUTS TARGET PRICE TO $14 FROM $16
Reuters · 2d ago
Abeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not Lost
Abeona Therapeutics Inc. Stock dropped by over half after receiving a Complete Response Letter from the FDA regarding its Biologics License Application for pz-cel. The FDA identified manufacturing issues that need to be resolved, delaying the potential approval of the gene therapy. Despite the setback, ABEO may present a buying opportunity as it bottoms out. The company estimates peak revenue of over $500 million in the U.S.
Seeking Alpha · 2d ago
Crude Oil Moves Higher; General Motors Earnings Top Views
The Dow traded up 0.68% to 38,499.41 while the NASDAQ rose 1.69%. The S&P 500 gained more than 1% on Tuesday. General Motors Company reported better-than-expected earnings for its fiscal first quarter. Hibbett, Inc. Shares shot up 19% after the company agreed to be acquired by JD Sports Fashion.
Benzinga · 2d ago
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation tumbled 6.5% to $179.20 on Tuesday. The company reported worse-than-expected quarterly financial results. Cyngn Inc. Shares jumped 100% after the company was chosen to supply John Deere with industrial automation. Pineapple Energy Inc. And Virgin Galactic Holdings, Inc. Were among the stocks moving in today's mid-day session.
Benzinga · 2d ago
KOPN, BTCM and CETX among mid-day movers
Seeking Alpha · 2d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
VolitionRX (AMEX:VNRX) shares rose 33.6% to $0.8 during Tuesday's regular session. Palisade Bio (NASDAQ:PALI) stock increased by 29.81% during the session. Kintara Therapeutics and NKGen Biotech were among the losers.
Benzinga · 2d ago
Dow Jumps Over 200 Points; US Services PMI Falls In April
U.S. Stocks traded higher midway through trading on Tuesday. The Dow Jones gained more than 200 points and the NASDAQ rose 1.44%. The S&P Global services PMI fell to 50.9 in April, recording the weakest level in five months. Cyngn Inc. Shares shot up 70% after being selected to supply John Deere's equipment. JetBlue Airways Corporation shares dropped 17% after the company reported first-quarter results.
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Neurocrine, SunPower, NextEra Energy
Dow Jones Industrial Average was up 0.53% at 38,444.3. Stocks like General Motors and Spotify rose on upbeat earnings updates. Growth and chip shares gained as growth and tech shares rose. Neurocrine, SunPower, NextEra Energy among the day's losers.
Reuters · 2d ago
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers
Seeking Alpha · 2d ago
Why Is Affirm (AFRM) Stock Moving Today?
Affirm (NASDAQ:AFRM) stock is falling on Tuesday after Walmart’s (NYSE:WMT) One launched its buy now pay later (BNPL) service. The retail giant is the majority owner of One. AFRM stock is down slightly alongside the Walmart and One news. Find out what's going on with shares of Tesla (TSLA) and Abeona Therapeutics (ABEO) stock today.
Investorplace · 2d ago
US Stocks Higher; PepsiCo Posts Upbeat Earnings
U.S. Stocks traded higher on Tuesday. The Dow traded up 0.23% to 38,328.19 while the NASDAQ rose 0.51%. PepsiCo reported upbeat earnings for its first quarter. In commodity news, oil traded down 0.3% to $81.69 while gold traded down 1.2%. Asian markets closed mostly higher.
Benzinga · 2d ago
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
Abeona Therapeutics Inc (NASDAQ:ABEO) announced a regulatory update for prademagene zamikeracel (pz-cel) The FDA has issued a Complete Response Letter in response to the company's BLA for the treatment of patients with recessive dystrophic epidermolysis bullosa.
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Calix, Fiserv, Quest Diagnostics
U.S. Stocks set to rise at open as some growth and chip stocks gain. Dow e-minis were up 0.28% in early trading. Spotify Technology, Fiserv, Quest Diagnostics among top percentage gainers. Investors digested a raft of quarterly earnings updates.
Reuters · 2d ago
Why Is Greenwave Technology Solutions (GWAV) Stock Down 47% Today?
Greenwave Technology Solutions (NASDAQ:GWAV) stock is down 46.6% on Tuesday morning. The metal recycling company announced a direct offering and private placement of shares of GWAV stock. Investors can find more of the latest stock market news available on Tuesday. Abeona Therapeutics stock, Magna stock and Pineapple Energy stock are all down today.
Investorplace · 2d ago
Abeona Therapeutics Price Target Maintained With a $36.00/Share by Cantor Fitzgerald
Dow Jones · 2d ago
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
Abeona Therapeutics (NASDAQ:ABEO) stock is falling on Tuesday after getting a Complete Response Letter (CRL) from the FDA. The FDA refused to approve Pz-cel for use in a clinical trial. ABEO stock is down 45.1% as of Tuesday morning. Pineapple Energy (PEGY) and HWH International (HWH) were the largest pre-market movers on Tuesday.
Investorplace · 2d ago
More
Webull provides a variety of real-time ABEO stock news. You can receive the latest news about Abeona Therapeut through multiple platforms. This information may help you make smarter investment decisions.
About ABEO
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cell and gene therapies for life-threatening diseases. The Company’s lead clinical program is for prademagene zamikeracel (pz-cel), its investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company’s fully integrated cell and gene therapy Good Manufacturing Practice (cGMP) manufacturing facility served as the manufacturing site for pz-cel used in its Phase III VIITAL trial and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. The Company’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases.